General Info
Cancer Research Horizons (CRT) develops and commercialises exciting new discoveries in cancer research.
Location: London
Country:
Industries:
Investment Regions: EU
Investment Stages: late-stage, pre-seed, seed, series-a
EU
Want to start building warm intros with this investor?
🤖 AI Activity Report
Status: very-active
AI Reasoning: Cancer Research Horizons public materials show investments in 2025: joined Myricx Bio’s Series A (reported Aug 20, 2025) and a major investment in Trogenix (reported mid‑2025). The most recent known investment occurred within the last 3 months from the reference date, with Myricx Bio (Series A) as the startup invested, so classify as very-active.
Here are the thresholds established for the different statuses:
Not Active – No known investments in the last 12 months.
Low Activity – Only known investments between the last 12 and 6 months.
Active – Known investments between the last 6 and 3 months.
Very Active – Known investments in the last 3 months.
Investor Contact
Team Members
Name
Role
Email
LinkedIn
…
…
…
…
…
Warm Intros from Portfolio Companies
Investment Regions Map
loading map…
Similar Investors
Other similar investors:
Latest on X (Twitter)
Access all contact details of Cancer Research Horizons
Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.
Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.
Trusted by Founders like You
Find your matching investors using AI